Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2019 by Scott Friedman and Andrea Vossler, Varia Ventures is based in Buffalo, New York. The firm manages several funds, including the AGA Fund, Dendrite Fund, SINC Fund, and Varia Fund, focusing on various healthcare sectors. Varia Ventures has a team of six members, including managing directors and venture partners.
Varia Ventures invests in healthcare companies at stages from Seed to pre-IPO, utilizing specialized funds tailored to specific sectors. The AGA Fund targets digestive diseases, the Dendrite Fund focuses on neuroscience, and the SINC Fund is dedicated to endoscopy and gastrointestinal investments. This approach allows Varia to create a curated portfolio of peer-reviewed investment opportunities.
Varia Ventures manages several funds: AGA Fund focuses on digestive diseases, Dendrite Fund concentrates on neuroscience, SINC Fund targets endoscopy and gastrointestinal investments, and Varia Fund invests in a broader range of healthcare deals.
Email info@varia.com with your deck to pitch Varia Ventures.
Varia Ventures typically participates in rounds but may lead depending on the specific investment opportunity and the fund involved.
The firm is open to follow-on investments, particularly in companies that align with their specialized funds and show promising growth potential.
Varia Ventures manages multiple funds, but specific fund sizes are not publicly disclosed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.